XLO Xilio Therapeutics, Inc.
Healthcare$8.35+1.21%ClosedMarket Cap: $50.0M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+10,000
Shares Acquired
10,000
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 16 | Blanchard Cheryl R | director | Sell | 10,000 | $8.40 | 10,000 |
| Thu Apr 16 | Blanchard Cheryl R | Sell | 0 | $0.00 | 0 | |
| Mon Mar 30 | Shannon James Samuel | director | Buy | 5,000 | $8.79 | 10,000 |
| Tue Feb 17 | GILEAD SCIENCES, INC. | 10 percent owner | Buy | 3,739,000 | $0.00 | 40,384,266 |
| Mon Jan 05 | Luptakova Katarina | officer: CHIEF MEDICAL OFFICER | Sell | 16,625 | $0.00 | 33,250 |
| Mon Jan 05 | Luptakova Katarina | officer: CHIEF MEDICAL OFFICER | Sell | 451,885 | $0.84 | 451,885 |
| Mon Jan 05 | Frankenfield Christopher James | officer: Chief Financial Officer | Sell | 19,375 | $0.00 | 38,750 |
| Mon Jan 05 | Frankenfield Christopher James | officer: Chief Financial Officer | Sell | 668,789 | $0.84 | 668,789 |
| Mon Jan 05 | Brennan Kevin M. | officer: SVP, FINANCE AND ACCOUNTING | Sell | 1,826 | $0.64 | 6,371 |
| Mon Jan 05 | Brennan Kevin M. | officer: SVP, FINANCE AND ACCOUNTING | Sell | 5,000 | $0.00 | 10,000 |
| Mon Jan 05 | Brennan Kevin M. | officer: SVP, FINANCE AND ACCOUNTING | Sell | 95,221 | $0.84 | 95,221 |